These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
126 related items for PubMed ID: 20163437
21. Use of intravenous levetiracetam for management of acute seizures in neonates. Khan O, Chang E, Cipriani C, Wright C, Crisp E, Kirmani B. Pediatr Neurol; 2011 Apr; 44(4):265-9. PubMed ID: 21397167 [Abstract] [Full Text] [Related]
22. Tolerability and dosing experience of intravenous levetiracetam in children and infants. Michaelides C, Thibert RL, Shapiro MJ, Kinirons P, John T, Manchharam D, Thiele EA. Epilepsy Res; 2008 Oct; 81(2-3):143-7. PubMed ID: 18571898 [Abstract] [Full Text] [Related]
23. Efficacy of levetiracetam: a review of three pivotal clinical trials. Privitera M. Epilepsia; 2001 Oct; 42 Suppl 4():31-5. PubMed ID: 11564123 [Abstract] [Full Text] [Related]
26. Levetiracetam: safety and efficacy in neonatal seizures. Ramantani G, Ikonomidou C, Walter B, Rating D, Dinger J. Eur J Paediatr Neurol; 2011 Jan; 15(1):1-7. PubMed ID: 21094062 [Abstract] [Full Text] [Related]
27. Rapid infusion of a loading dose of intravenous levetiracetam with minimal dilution: a safety study. Wheless JW, Clarke D, Hovinga CA, Ellis M, Durmeier M, McGregor A, Perkins F. J Child Neurol; 2009 Aug; 24(8):946-51. PubMed ID: 19264738 [Abstract] [Full Text] [Related]
28. Levetiracetam in patients with epilepsy and chronic liver disease: observations in a case series. Bilo L, Meo R, de Leva MF, De Simone R, Di Nocera P, Pisani F, Striano S. Clin Neuropharmacol; 2008 Aug; 31(4):221-5. PubMed ID: 18670245 [Abstract] [Full Text] [Related]
29. Efficacy and tolerability of adjunctive therapy with zonisamide in childhood intractable epilepsy. Lee YJ, Kang HC, Seo JH, Lee JS, Kim HD. Brain Dev; 2010 Mar; 32(3):208-12. PubMed ID: 19304420 [Abstract] [Full Text] [Related]
30. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy. Shinnar S, Pellock JM, Conry JA. Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174 [Abstract] [Full Text] [Related]
31. Effects of levetiracetam on seizure frequency and neuropsychological impairments in children with refractory epilepsy with secondary bilateral synchrony. Kanemura H, Sano F, Sugita K, Aihara M. Seizure; 2013 Jan; 22(1):43-7. PubMed ID: 23127775 [Abstract] [Full Text] [Related]
38. Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center. Bootsma HP, Ricker L, Diepman L, Gehring J, Hulsman J, Lambrechts D, Leenen L, Majoie M, Schellekens A, de Krom M, Aldenkamp AP. Epilepsy Behav; 2007 Mar; 10(2):296-303. PubMed ID: 17317325 [Abstract] [Full Text] [Related]
39. Pyridoxal phosphate is better than pyridoxine for controlling idiopathic intractable epilepsy. Wang HS, Kuo MF, Chou ML, Hung PC, Lin KL, Hsieh MY, Chang MY. Arch Dis Child; 2005 May; 90(5):512-5. PubMed ID: 15851435 [Abstract] [Full Text] [Related]